InBody Co.Ltd (041830) — Capital Reinvestment Ratio
InBody Co.Ltd (041830) has a Capital Reinvestment Ratio of 0.40x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩9.04 Billion) in capital expenditures (₩3.64 Billion). See InBody Co.Ltd (041830) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
InBody Co.Ltd Capital Reinvestment Ratio (2011–2024)
This chart tracks InBody Co.Ltd's Capital Reinvestment Ratio across 14 annual periods. Check InBody Co.Ltd (041830) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for InBody Co.Ltd (2011–2024)
Year-by-year Capital Reinvestment Ratio for InBody Co.Ltd from 2011 to 2024. For live market cap and broader valuation context, see InBody Co.Ltd (041830) total market value.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.26x | ₩28.58 Billion | ₩7.55 Billion | ▲ +33.8% |
| 2023 | 0.20x | ₩38.69 Billion | ₩7.64 Billion | ▼ -0.1% |
| 2022 | 0.20x | ₩30.42 Billion | ₩6.02 Billion | ▼ -47.6% |
| 2021 | 0.38x | ₩30.35 Billion | ₩11.45 Billion | ▲ +537.4% |
| 2020 | 0.06x | ₩28.50 Billion | ₩1.69 Billion | ▼ -53.4% |
| 2019 | 0.13x | ₩24.21 Billion | ₩3.08 Billion | ▼ -94.5% |
| 2018 | 2.31x | ₩17.70 Billion | ₩40.86 Billion | ▲ +707.1% |
| 2017 | 0.29x | ₩18.58 Billion | ₩5.31 Billion | ▼ -37.9% |
| 2016 | 0.46x | ₩18.24 Billion | ₩8.41 Billion | ▼ -31.8% |
| 2015 | 0.68x | ₩11.18 Billion | ₩7.55 Billion | ▲ +372.3% |
| 2014 | 0.14x | ₩10.26 Billion | ₩1.47 Billion | ▼ -89.2% |
| 2013 | 1.32x | ₩6.99 Billion | ₩9.26 Billion | ▲ +609.8% |
| 2012 | 0.19x | ₩4.36 Billion | ₩812.05 Million | ▼ -57.4% |
| 2011 | 0.44x | ₩5.50 Billion | ₩2.41 Billion | — |